<p><i>A</i>. Time course of TER of HUVEC monolayers transfected with WT and DN Rac1 plasmids, treated with either 2 μM S1P or vehicle (N = 8 each group). The TER is normalized to the time point just prior to addition of S1P for a more direct comparison of the magnitude of the response. <i>B</i>. The mean maximal change in TER (%) of HUVEC monolayers in the 10-min window immediately following S1P treatment. The corresponding data for HDMEC monolayers are shown in panels <i>C & D</i> (N = 8 each group). *P<0.05 vs. Vehicle treated groups.</p
<p>(A) RhoA, Rac1 or Cdc42 were silenced in HUVECs using 100 nM siRNA for 72 hours, and the cell lys...
<p>(A) Confluent HUVEC monolayers were pre-treated with/without G-1 (1 µM) for 45 minutes prior to 1...
<p>(A) Quiescent EA.hy 926 human endothelial cells were treated for 10 min with either vehicle (Co) ...
<p>A. Time course of changes in TER of HUVEC monolayers before and after treatment with 2 μM S1P or ...
<p><i>A</i>. Treatment with the selective Rac1 inhibitor Z62954982 reduces TER in a concentration-de...
<p><i>A</i>. Maximal change in TER (%) from baseline within the initial 10-min time window after add...
<p><i>A</i>. Time course of changes in TER of HUVEC monolayers treated with 1 U/ml thrombin or vehic...
<p>A: Effect on TER of the primary RPMVEC monolayer. Compared with controls, TER of primary RPMVEC m...
<p><i>A</i>. <i>P</i><sub>s</sub><sup>albumin</sup> of HUVEC monolayers expressing GFP, GFP-Rac1-WT,...
<p>TER measurements were carried out to monitor endothelial barrier alterations in response to diffe...
<p>(A) Representative Western blot for HUVEC protein lysates probed with anti-ANKS1B antibody after ...
<p>A: The amount of FITC-dextran that passed through monolayers of HUVECs treated with control siRNA...
<p><b>(A)</b> TEER assay to evaluate the effect of NS1 proteins from DENV1-4 and WNV (5 μg/ml) on HP...
<p>A—Quantification of the area under the response curve (AUC) of HUVECs transfected with 71 differe...
<p>(A) and (B) HUVEC-CM protected VE-cadherin from VEGF and pro-inflammatory cytokines. The upper pa...
<p>(A) RhoA, Rac1 or Cdc42 were silenced in HUVECs using 100 nM siRNA for 72 hours, and the cell lys...
<p>(A) Confluent HUVEC monolayers were pre-treated with/without G-1 (1 µM) for 45 minutes prior to 1...
<p>(A) Quiescent EA.hy 926 human endothelial cells were treated for 10 min with either vehicle (Co) ...
<p>A. Time course of changes in TER of HUVEC monolayers before and after treatment with 2 μM S1P or ...
<p><i>A</i>. Treatment with the selective Rac1 inhibitor Z62954982 reduces TER in a concentration-de...
<p><i>A</i>. Maximal change in TER (%) from baseline within the initial 10-min time window after add...
<p><i>A</i>. Time course of changes in TER of HUVEC monolayers treated with 1 U/ml thrombin or vehic...
<p>A: Effect on TER of the primary RPMVEC monolayer. Compared with controls, TER of primary RPMVEC m...
<p><i>A</i>. <i>P</i><sub>s</sub><sup>albumin</sup> of HUVEC monolayers expressing GFP, GFP-Rac1-WT,...
<p>TER measurements were carried out to monitor endothelial barrier alterations in response to diffe...
<p>(A) Representative Western blot for HUVEC protein lysates probed with anti-ANKS1B antibody after ...
<p>A: The amount of FITC-dextran that passed through monolayers of HUVECs treated with control siRNA...
<p><b>(A)</b> TEER assay to evaluate the effect of NS1 proteins from DENV1-4 and WNV (5 μg/ml) on HP...
<p>A—Quantification of the area under the response curve (AUC) of HUVECs transfected with 71 differe...
<p>(A) and (B) HUVEC-CM protected VE-cadherin from VEGF and pro-inflammatory cytokines. The upper pa...
<p>(A) RhoA, Rac1 or Cdc42 were silenced in HUVECs using 100 nM siRNA for 72 hours, and the cell lys...
<p>(A) Confluent HUVEC monolayers were pre-treated with/without G-1 (1 µM) for 45 minutes prior to 1...
<p>(A) Quiescent EA.hy 926 human endothelial cells were treated for 10 min with either vehicle (Co) ...